Search details
1.
Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial.
Rheumatology (Oxford)
; 2024 Feb 17.
Article
in English
| MEDLINE | ID: mdl-38366929
2.
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis.
Rheumatology (Oxford)
; 63(1): 226-234, 2024 Jan 04.
Article
in English
| MEDLINE | ID: mdl-37154625
3.
Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study.
Rheumatology (Oxford)
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38745439
4.
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 02.
Article
in English
| MEDLINE | ID: mdl-38430476
5.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Article
in English
| MEDLINE | ID: mdl-38460548
6.
Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography.
J Rheumatol
; 51(3): 270-276, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38302169
7.
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease.
Rheumatol Int
; 2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38506924
8.
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis.
Thorax
; 78(12): 1188-1196, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37798114
9.
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells.
Rheumatology (Oxford)
; 62(SI): SI125-SI137, 2023 02 06.
Article
in English
| MEDLINE | ID: mdl-35900177
10.
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.
Rheumatology (Oxford)
; 62(SI): SI43-SI53, 2023 02 06.
Article
in English
| MEDLINE | ID: mdl-35640959
11.
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities.
Rheumatology (Oxford)
; 2023 Oct 05.
Article
in English
| MEDLINE | ID: mdl-37796832
12.
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
Rheumatology (Oxford)
; 62(SI): SI91-SI100, 2023 02 06.
Article
in English
| MEDLINE | ID: mdl-35904554
13.
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease.
Rheumatology (Oxford)
; 62(2): 696-706, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-35708639
14.
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Rheumatology (Oxford)
; 62(12): 3785-3800, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37335850
15.
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production.
Rheumatology (Oxford)
; 62(10): 3469-3479, 2023 10 03.
Article
in English
| MEDLINE | ID: mdl-36802235
16.
Persistence of remission after lengthening of golimumab in inflammatory joint diseases.
Clin Exp Rheumatol
; 41(5): 1088-1095, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36622116
17.
Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction.
Clin Exp Rheumatol
; 41(2): 330-339, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36861746
18.
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort.
Clin Exp Rheumatol
; 41(3): 735-743, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36226614
19.
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes.
BMC Pulm Med
; 23(1): 472, 2023 Nov 25.
Article
in English
| MEDLINE | ID: mdl-38007479
20.
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review.
Int J Mol Sci
; 24(4)2023 Feb 17.
Article
in English
| MEDLINE | ID: mdl-36835506